How do I buy Doximity (DOCS) stock?

Buying Doximity (DOCS) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "DOCS", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy DOCS by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if DOCS is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Doximity (DOCS) Stock

Q: What is the minimum investment for DOCS on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Doximity from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NEW YORK STOCK EXCHANGE INC. · DOCS

Trade DOCS

Key stats

Market cap: $5.93B
Price / Earnings ratio: 41.4x
EPS (TTM): $0.76
Volume: Loading
52-week high: $54.04
52-week low: $17.15
EPS vs analyst estimate: +32.4%Q2 FY26 · $0.45 vs $0.34

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with DOCS

Technical indicators

RSI 14: 57.75
MACD 12/26/9: 0.99
EMA 9 of MACD: 1.27
MACD histogram: -0.29
SMA 50: $29.47; Price above SMA 50
EMA 50: $30.07; Price above EMA 50
SMA 200: $25.25; Price above SMA 200
EMA 200: $29.53; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 6 analyst ratings

Strong Sell0

Sell0

Hold3

Buy3

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2022

2023

2024

2025

2026

774M511M255M0

Debt & Balance Sheet

Total assets

Total liabilities

2022

2023

2024

2025

2026

2B1B501M0

Revenue to Profit

2026

$644.9M

Revenue

$0.0

Cost of revenue

$574.5M

Gross profit

$0.0

Operating expenses

$196.1M

Net income

Earnings

EPS forecast

Actual EPS

$0.45

$0.34

Q2FY26

$0.40

Q3FY26

$0.27

Q4FY26

$0.26

Q1FY27

$0.33

Q2FY27

The market is expecting earnings per share of $0.33 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Doximity

Doximity, Inc. is a prominent American digital platform dedicated to connecting medical professionals and enabling collaboration within the healthcare industry. Established in 2010 and headquartered in San Francisco, California, Doximity provides a secure and private network for doctors, physicians, and other healthcare professionals to communicate, share knowledge, and collaborate on patient care. The platform offers various features such as telemedicine services, medical news, professional networking, and opportunities for career advancement, making it a valuable tool for the healthcare community. By leveraging technology to facilitate seamless communication and information sharing, Doximity aims to enhance healthcare outcomes and drive advancements in the medical field.

SectorHealthcare

IndustryHealth Information Services

Employees880

CEOMr. Jeffrey A. Tangney

IPO DateJun 24, 2021

HeadquartersSan Francisco, CA

Key Executives

Name	Title	Year Born
Mr. Jeffrey A. Tangney	Co-Founder, CEO & Chairperson	1973
Mr. Matthew Sonefeldt	CFO & Principal Financial Officer	1980
Mr. Siddharth Sitaram	Chief Accounting Officer	1978
Mr. John T. Vaughan	General Counsel, Corporate Secretary & Chief Compliance Officer	1975
Dr. Steven L. Zatz M.D.	President	1957
Mr. Jey Balachandran	Chief Technology Officer	—
Mr. Perry Scott Gold	Head of Investor Relations	—
Mr. Bruno Miranda	Senior Vice President of Engineering	—
Mr. Joel Davis	Senior Vice President of Product	—
Mr. Ben Greenberg	Senior VP & GM Commercial Products	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-4.4	-22.6
2022	-11.6	+24.8	-10.4	-24.5	-15.5	-2.0	+15.3	-22.5	-7.6	-13.1	+29.6	-3.5
2023	+7.4	-9.8	-1.8	+16.7	-14.3	+7.8	+8.5	-31.5	-12.9	-3.6	+14.4	+15.2
2024	-5.6	+2.7	-4.1	-8.0	+15.5	+1.2	+1.9	+34.3	+21.4	-3.4	+25.1	-0.0
2025	+10.3	+19.3	-15.2	+0.3	-10.3	+19.1	+0.6	+18.5	+9.2	-6.6	-23.2	-13.3
2026	-13.4	-34.2	-9.3	+6.6	-14.3	-8.0	-3.1	+23.3	+7.6	+14.9	+1.1

Stocks in the same sector

EVH

Evolent Health, Inc. - Class A Shares

FAQ

Buying Doximity (DOCS) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "DOCS", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy DOCS by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Doximity from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Doximity (DOCS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track DOCS's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Doximity (DOCS) Stock

Key stats

Compare with DOCS

Recent news

Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors

Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors

Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

Why Doximity (DOCS) Dipped More Than Broader Market Today

Why Doximity (DOCS) Dipped More Than Broader Market Today

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Doximity Deepens U.S. News Alliance to Improve Patient Access to Care

Doximity Deepens U.S. News Alliance to Improve Patient Access to Care

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors

Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing

Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing

About Doximity

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade